Synonyms: Cubicin® | LY-146032 | LY146032
daptomycin is an approved drug (FDA (2003), EMA (2006))
Compound class:
Synthetic organic
Comment: Daptomycin is a semi-synthetic cyclic lipopeptide antibacterial with broad-spectrum activity against Gram-positive bacteria. It is a bacterial metabolite that was isolated from Streptomyces roseosporus. Daptomycin rapidly depolarizes the bacterial cell membrane which disrupts DNA, RNA and protein synthesis and results in cell death.
This antibacterial was removed from the World Health Organization's List of Essential Medicines in 2019. |
|
No information available. |
Summary of Clinical Use ![]() |
Daptomycin is used to treat complicated bacterial infections of the skin and soft tissues, Staphylococcus aureus bacteraemia, and MRSA. |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |